1921
Volume 73, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

The prevalence of chloroquine (CQ) treatment failure and the genotype failure index was determined in four sentinel sites in Burkina Faso. In three sites, the genotype failure index varied between 1.7 and 3, a result confirming the relationship between the CQ resistance transporter () T76 mutation and CQ resistance. In the remaining site, the genotype failure index was unusually low, 1.1, which was significantly different than that in the other sites ( < 0.00001). These findings are discussed. Often but not always, the prevalence of CQ resistance can be correctly estimated by the T76 genotype failure index.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2005.73.171
2005-07-01
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/73/1/0730171.html?itemId=/content/journals/10.4269/ajtmh.2005.73.171&mimeType=html&fmt=ahah

References

  1. Djimde A, Doumbo OK, Steketee RW, Plowe CV, 2001. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358 : 890–891.
  2. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, 2001. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis 183 : 1535–1538.
  3. Basco LK, Ringwald P, 2001. Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon. J Infect Dis 183 : 1828–1831.
  4. Chen N, Russell B, Staley J, Kotecka B, Nasveld P, Cheng Q, 2001. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J Infect Dis 183 : 1543–1545.
  5. Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Pomphida S, Inkathone S, Zhong K, Kain KC, 2001. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183 : 789–795.
  6. Tinto H, Zoungrana EB, Coulibaly SO, Ouédraogo JB, Traoré M, Guiguemdé TR, van Marck E, D’Alessandro U, 2002. Chloroquine and sulfadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso, during a 3-year period (1998–2000). Trop Med Int Health 7 : 925–930.
  7. World Health Organization, 2002. Monitoring Antimalarial Resistance. Geneva: World Health Organization. WHO/CDS/ CSR/EPH/ 2002.17.
  8. Plowe CV, Djimdé A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-confering mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52 : 565–568.
  9. Tinto H, Ouédraogo JB, Erhart A, van Overmeir C, Dujardin C, van Marck E, Guiguemdé TR, D’Alessandro U, 2003. Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol 3 : 287–292.
  10. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344 : 257–263.
  11. Jelinek T, Aida AO, Peyerl-Hoffmann G, Jordan S, Mayor A, Heuschkel C, El Valy AO, von Sonnenburg F, Christophel EM, 2002. Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in southern Mauritania. Am J Trop Med Hyg 67 : 449–453.
  12. Mboup S, Wypij D, Maguire JH, Wirth DF, 2002. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg 66 : 474–480.
  13. Rason MA, Ariey F, Rafidimanantsoa L, Andrianantenaina BH, Sahondra Harisoa JL, Randrianarivelojosia M, 2002. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Parasite 9 : 247–253.
  14. Ouedraogo JB, Dutheil Y, Tinto H, Traore B, Zampa H, Tall F, Coulibaly SO, Guiguemde TR, 1998. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (west Africa). Trop Med Int Health 3 : 381–384.
  15. Diabaté A, Baldet T, Chandre F, Dabiré KR, Kengne P, Simard F, Guiguemdé TR, Guillet P, Hemingway J, Hougard JM, 2003. Kdr mutation, a genetic marker to assess events of introgression between the molecular M and S forms of Anopheles gambiae (Diptera, Culicidae) in the tropical savannah area of west Africa. J Med Entomol 40 : 195–198.
  16. Abdel-Muhsin A, Mackinnon MJ, Ali E, Nassir EKA, Suleiman S, Ahmed S, Walliker D, Babiker HA, 2004. Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in eastern Sudan. J Infect Dis 189 : 1239–1244.
  17. Talisuna AO, Langi P, Bakyaita N, Egwang T, Mutabingwa TK, Watkins W, van Marck E, D’Alessandro U, 2002. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg 96 : 310–317.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2005.73.171
Loading
/content/journals/10.4269/ajtmh.2005.73.171
Loading

Data & Media loading...

  • Received : 12 Jul 2004
  • Accepted : 20 Dec 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error